<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107687">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02046863</url>
  </required_header>
  <id_info>
    <org_study_id>1R43NS081902-01</org_study_id>
    <secondary_id>1R43NS081902</secondary_id>
    <nct_id>NCT02046863</nct_id>
  </id_info>
  <brief_title>Pilot Study for Automated Deep Brain Stimulation Programming</brief_title>
  <official_title>DBS-Expert: Automated Deep Brain Stimulation Programming Using Functional Mapping - Phase I</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Great Lakes NeuroTechnologies Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Great Lakes NeuroTechnologies Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The clinical utility of deep brain stimulation (DBS) for the treatment of movement disorders
      such as Parkinson's disease has been well established; however, there is a great disparity
      in outcomes among DBS recipients due to varied postoperative management, particularly
      concerning the choosing of an optimal set of programming parameters from the thousands of
      possible combinations. This study will evaluate the use of motion sensor based assessments
      to develop a functional map and algorithms to automatically determine a set of programming
      parameters that maximize symptomatic benefits while minimizing side effects and battery
      consumption.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Change from Baseline in Unified Parkinson's Disease Rating Scale III Score After Guided DBS Programming</measure>
    <time_frame>Within two days of standard clinical DBS programming session</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Kinesia HomeView Symptom Ratings After Guided DBS Programming</measure>
    <time_frame>Within two days of standard clinical DBS programming session</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Parkinson's Disease</condition>
  <condition>Tremor</condition>
  <condition>Bradykinesia</condition>
  <arm_group>
    <arm_group_label>Automated Programming</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will have DBS settings changed as guided by prototype DBS-Expert software. Tremor, bradykinesia, and dyskinesia will be assessed at each DBS setting.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Automated Programming</intervention_name>
    <description>Prototype DBS-Expert software will be used to guide a clinician through DBS programming.</description>
    <arm_group_label>Automated Programming</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of idiopathic Parkinson's disease

          -  Implanted deep brain stimulation system awaiting initial programming session

        Exclusion Criteria:

          -  Subjects with significant psychiatric illness or dementia

          -  Significant cognitive impairment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dustin A Heldman, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Great Lakes NeuroTechnologies</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Cincinnati Department of Neurology</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maureen Gartner, MSN, NP-C</last_name>
      <phone>513-558-2968</phone>
    </contact>
    <investigator>
      <last_name>Fredy Revilla, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 24, 2014</lastchanged_date>
  <firstreceived_date>December 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Parkinson's disease</keyword>
  <keyword>Tremor</keyword>
  <keyword>Bradykinesia</keyword>
  <keyword>Deep brain stimulation</keyword>
  <keyword>Kinesia</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Tremor</mesh_term>
    <mesh_term>Hypokinesia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
